CDK4/6-IN-15
CDK4/6-IN-15 is an orally active and selective CDK4/6 inhibitor. CDK4/6-IN-15 potently inhibits cancer cells growth. CDK4/6-IN-15 arrests cell cycle at G1 phase and suppresses retinoblastoma tumour suppressor protein (Rb) phosphorylation at S780 and E2 factor (E2F) -regulated gene expression[1].
Product Specifications
CAS Number
2078047-99-9
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk4-6-in-15.html
Purity
99.32
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CNC1=NC(C)=C(C2=NC(NC3=NC=C(N4CCC(N(C)C)CC4)C=C3)=NC=C2F)S1
Molecular Formula
C21H27FN8S
Molecular Weight
442.56
References & Citations
[1]Tadesse S, et al. Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agents. Br J Pharmacol. 2018 Jun;175 (12) :2399-2413.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; CDK4; CDK6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC425352 20 µg
FAM164B (ZC2HC1B) (NM_001013623) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNUM3099-50 1x 50 µL
RNA Polymerase II CTD Repeat YSPTSPS (Phospho S5) (CTD 8A7), 1mg/mL
Sign In for Pricing
View Details 
BNUB1648-500 1x 500 µL
TIMP1 (Marker of Lymph Node Metastasis) (2A5), 0.2mg/mL
Sign In for Pricing
View Details